Westside Investment Management, Inc. Inmune Bio, Inc. Transaction History

Westside Investment Management, Inc.

$626 Billion
Q3 2025

A detailed history of Westside Investment Management, Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 103,450 shares of INMB stock, worth $150,002. This represents 0.03% of its overall portfolio holdings.

Number of Shares

103,450

Previous 21,375 383.98%

Holding current value

$150,002

Previous $49.4 Million 333.69%

% of portfolio

0.03%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$1.76 - $2.91 $144,452 - $238,838	82,075 Added 383.98%	103,450 $214 Million
Q2 2025 Aug 05, 2025	SELL	$2.31 - $8.26 $156,675 - $560,234	-67,825 Reduced 76.04%	21,375 $49.4 Million
Q1 2025 Apr 25, 2025	SELL	$4.93 - $10.48 $3,820 - $8,122	-775 Reduced 0.86%	89,200 $697 Million
Q4 2024 Jan 17, 2025	BUY	$4.4 - $6.43 $82,104 - $119,983	18,660 Added 26.17%	89,975 $420 Million
Q3 2024 Nov 20, 2024	BUY	$4.86 - $9.86 $126,238 - $256,113	25,975 Added 57.29%	71,315 $384 Million

Q2 2024 Jul 17, 2024	BUY	$7.15 - $11.84 $78,292 - $129,648	10,950 Added 31.84%	45,340 $400 Million
Q1 2024 Apr 19, 2024	SELL	$10.53 - $14.01 $78,711 - $104,724	-7,475 Reduced 17.86%	34,390 $404 Million
Q4 2023 Jan 12, 2024	BUY	$6.6 - $11.52 $2,145 - $3,744	325 Added 0.78%	41,865 $471 Million
Q3 2023 Nov 15, 2023	SELL	$6.61 - $10.9 $4,627 - $7,630	-700 Reduced 1.66%	41,540 $281 Million
Q2 2023 Jul 14, 2023	BUY	$6.5 - $10.09 $33,377 - $51,812	5,135 Added 13.84%	42,240 $384 Million
Q1 2023 May 17, 2023	BUY	$6.01 - $10.18 $40,357 - $68,358	6,715 Added 22.1%	37,105 $240 Million
Q4 2022 Jan 31, 2023	BUY	$6.13 - $7.96 $919 - $1,194	150 Added 0.5%	30,390 $192,000
Q3 2022 Nov 09, 2022	BUY	$6.04 - $10.44 $604 - $1,044	100 Added 0.33%	30,240 $187,000
Q2 2022 Jul 15, 2022	BUY	$5.48 - $8.97 $20,550 - $33,637	3,750 Added 14.21%	30,140 $266,000
Q1 2022 Apr 25, 2022	BUY	$6.42 - $11.39 $119,347 - $211,740	18,590 Added 238.33%	26,390 $222,000
Q4 2021 Feb 15, 2022	BUY	$9.97 - $20.38 $77,766 - $158,964	7,800 New	7,800 $79,000

Others Institutions Holding INMB

# of Institutions

Shares Held

5.36M

Call Options Held

310K

Put Options Held

371K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $26M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.

Account

Westside Investment Management, Inc. Inmune Bio, Inc. Transaction History